LU87335A1 - USE OF WATER-SOLUBLE MONOESTERS OF FATTY ACIDS AS DRUG SOLUBILIZERS - Google Patents

USE OF WATER-SOLUBLE MONOESTERS OF FATTY ACIDS AS DRUG SOLUBILIZERS

Info

Publication number
LU87335A1
LU87335A1 LU87335A LU87335A LU87335A1 LU 87335 A1 LU87335 A1 LU 87335A1 LU 87335 A LU87335 A LU 87335A LU 87335 A LU87335 A LU 87335A LU 87335 A1 LU87335 A1 LU 87335A1
Authority
LU
Luxembourg
Prior art keywords
water
fatty acids
drug solubilizers
soluble monoesters
monoesters
Prior art date
Application number
LU87335A
Other languages
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87335A1 publication Critical patent/LU87335A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU87335A 1987-09-15 1988-09-12 USE OF WATER-SOLUBLE MONOESTERS OF FATTY ACIDS AS DRUG SOLUBILIZERS LU87335A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (1)

Publication Number Publication Date
LU87335A1 true LU87335A1 (en) 1989-04-06

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87335A LU87335A1 (en) 1987-09-15 1988-09-12 USE OF WATER-SOLUBLE MONOESTERS OF FATTY ACIDS AS DRUG SOLUBILIZERS

Country Status (24)

Country Link
JP (1) JP3090666B2 (en)
KR (1) KR0131084B1 (en)
AT (1) AT395819B (en)
AU (1) AU628787B2 (en)
BE (1) BE1001204A5 (en)
CA (1) CA1338775C (en)
CH (1) CH683672A5 (en)
DK (1) DK175132B1 (en)
ES (1) ES2012118A6 (en)
FI (1) FI94837C (en)
FR (1) FR2620336B1 (en)
GB (1) GB2209671B (en)
GR (1) GR1002243B (en)
HU (1) HU205010B (en)
IE (1) IE61195B1 (en)
IL (1) IL87746A (en)
IT (1) IT1224886B (en)
LU (1) LU87335A1 (en)
MY (1) MY103769A (en)
NL (1) NL195094C (en)
NO (1) NO179434C (en)
NZ (1) NZ226163A (en)
PT (1) PT88492B (en)
SE (1) SE503279C2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (en) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 Pharmaceutical composition containing cyclosporin
GR1000466B (en) * 1989-01-28 1992-07-30 Sandoz Ag Preparation method of novel pharmaceutical forms of cyclosporine
BE1003009A5 (en) * 1989-02-09 1991-10-22 Sandoz Sa NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON CYCLOSPORINS.
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (en) 1992-09-25 2002-04-02 Novartis Ag Cyclosporin-containing pharmaceutical preparations
ES2308955T5 (en) * 1993-09-28 2012-04-03 R.P. Scherer Gmbh Manufacture of soft gelatin capsules
ES2177652T3 (en) 1994-11-03 2002-12-16 Novartis Ag NEW FORMS OF PREPARATION OF CYCLOSPORINE FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY, AND PROCEDURE FOR OBTAINING IT.
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19544507B4 (en) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin containing preparations
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
KR20050084502A (en) 1997-01-30 2005-08-26 노파르티스 아게 Oil-free pharmaceutical compositions containing cyclosporin a
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
WO2005037252A1 (en) * 2003-10-14 2005-04-28 Wockhardt Limited Sterile gelling agents
JP5422871B2 (en) * 2006-10-24 2014-02-19 不二製油株式会社 Isoflavones composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284933A (en) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (en) * 1966-11-22 1968-06-21
BE787842A (en) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd PROCESS FOR PREPARING AN AQUEOUS SUSPENSION OF STABLE CRYSTALS OF THE NON-BETA TYPE OF HIGHER FATTY ACID ESTERS OF CHLORAMPHENICOL
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
SE445174B (en) * 1978-03-07 1986-06-09 Sandoz Ag PHARMACEUTICAL COMPOSITION CONTAINING A CYCLOSPORIN AND A HEALING SUBSTANCE
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (en) * 1985-04-04 1986-12-11 Kanji Takada Lymph orienting preparation of cyclosporin

Also Published As

Publication number Publication date
KR890004694A (en) 1989-05-09
IE882772L (en) 1989-03-15
GR880100602A (en) 1989-06-22
IL87746A (en) 1992-07-15
DK511188D0 (en) 1988-09-14
ES2012118A6 (en) 1990-03-01
SE503279C2 (en) 1996-05-13
ATA224988A (en) 1992-08-15
IE61195B1 (en) 1994-10-19
DK175132B1 (en) 2004-06-14
IT1224886B (en) 1990-10-24
BE1001204A5 (en) 1989-08-16
DK511188A (en) 1989-03-16
JPH01151526A (en) 1989-06-14
FI94837B (en) 1995-07-31
GB2209671B (en) 1991-11-13
FI884192L (en) 1989-03-16
AU628787B2 (en) 1992-09-24
GB2209671A (en) 1989-05-24
NL8802275A (en) 1989-04-03
IT8848349A0 (en) 1988-09-14
IL87746A0 (en) 1989-02-28
MY103769A (en) 1993-09-30
HUT49494A (en) 1989-10-30
FR2620336B1 (en) 1991-10-25
KR0131084B1 (en) 1998-04-17
CA1338775C (en) 1996-12-10
GB8821443D0 (en) 1988-10-12
FI94837C (en) 1995-11-10
NO179434C (en) 1996-10-09
PT88492A (en) 1988-10-01
NO884052L (en) 1989-03-16
NO884052D0 (en) 1988-09-13
AT395819B (en) 1993-03-25
SE8803221L (en) 1989-03-16
FI884192A0 (en) 1988-09-13
HU205010B (en) 1992-03-30
NZ226163A (en) 1991-08-27
CH683672A5 (en) 1994-04-29
JP3090666B2 (en) 2000-09-25
NL195094C (en) 2003-12-17
SE8803221D0 (en) 1988-09-13
GR1002243B (en) 1996-04-22
FR2620336A1 (en) 1989-03-17
AU2217288A (en) 1989-04-27
NO179434B (en) 1996-07-01
PT88492B (en) 1993-03-31

Similar Documents

Publication Publication Date Title
FR2620336B1 (en) USE OF WATER-SOLUBLE MONOESTERS OF FATTY ACIDS AS DRUG SOLUBILIZERS
FI885651A7 (en) Process for the preparation of optically active 3-desmethylmevalonic acid derivatives and intermediates
AU7194691A (en) Therapeutic use of indole-3-yl-carboxylic acid endo-8- methyl-8-aza-bicyclo(3,2,1)oct-3-yl ester
ES524032A0 (en) PROCEDURE FOR THE PREPARATION OF CONTINUOUS AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
IL83919A0 (en) Preparation of benzoic acid derivatives
AU609034B2 (en) Fungicidal acrylic acid derivatives and intermediates
NO873923L (en) PROCEDURE FOR THE PREPARATION OF A MEDICAL SKIN PREPARATION
FR2647445B1 (en) N-CARBOALKYLOXY AMINO-11 UNDECANOIC ACIDS AND THEIR ESTERS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS THICKENERS
AU8680691A (en) Intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2608159B1 (en) NOVEL DERIVATIVES OF FURANNURONIC ACID, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR2640263B1 (en) PREPARATION OF LEVULINIC ACID
IT1211673B (en) PREPARATION PROCEDURE FOR UNSATURATED CARBOXYLIC ACID ESTERS
ZA891534B (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
BE893324A (en) PREPARATION OF CARBOXYLIC ACID ESTERS
NO933016D0 (en) PROCEDURE FOR SAFE ADMINISTRATION OF FATTY ACID
TR24836A (en) PROCESS FOR THE PREPARATION OF PIRID'S CARBOCYLIC ACID DERIVATIVES
FR2650290B1 (en) POLYSULFURATED COMPOSITIONS OF UNSATURATED FATTY BODIES? AND / OR ESTERS OF (POLY) UNSATURATED ACIDS, AND POSSIBLY OLEFINS, THEIR PREPARATION AND THEIR USE
FR2535322B1 (en) PREPARATION OF AMINOCYCLOPENTANIC ACIDS
TR23881A (en) PREPARATION METHOD OF N-SUELFOMETIL ACRYLAMID ACRYLIC ACID TERPOLIMERS FROM POLYACRYLONITRILE
IT1216806B (en) ESTERS OF ALCHYLPOLYOXYLIC ACIDS LENCARBOXYLIC, THEIR PREPARATION AND THEIR USE AS SURFACTANTS
AU7344887A (en) Preparation of fatty acids
NO933017D0 (en) PROCEDURE FOR SAFE ADMINISTRATION OF FATTY ACID
OA07756A (en) New derivatives of aryloxybenzoic acids and their use as herbicides.
PT87861A (en) PREPARATION OF A PIPERIDINYLCYCLOPENTYLHEPTENOIC ACID DERIVATIVE
FR2696467B1 (en) Process for the preparation of fatty acid monoesters of D-fructose and their use in the cosmetic, oral, pharmaceutical and food fields.